268 related articles for article (PubMed ID: 21483829)
1. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.
Smith JL; Reloj AR; Nataraj PS; Bartos DC; Schroder EA; Moss AJ; Ohno S; Horie M; Anderson CL; January CT; Delisle BP
Am J Physiol Cell Physiol; 2013 Nov; 305(9):C919-30. PubMed ID: 23864605
[TBL] [Abstract][Full Text] [Related]
3. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
[TBL] [Abstract][Full Text] [Related]
4. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.
Balijepalli SY; Lim E; Concannon SP; Chew CL; Holzem KE; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT
Circulation; 2012 Dec; 126(24):2809-18. PubMed ID: 23136156
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
[TBL] [Abstract][Full Text] [Related]
7. Novel characteristics of a trafficking-defective G572R-hERG channel linked to hereditary long QT syndrome.
Lian J; Huang N; Zhou J; Ge S; Huang X; Huo J; Liu L; Xu W; Zhang S; Yang X; Zhou J; Huang C
Can J Cardiol; 2010 Oct; 26(8):417-22. PubMed ID: 20931094
[TBL] [Abstract][Full Text] [Related]
8. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
[TBL] [Abstract][Full Text] [Related]
9. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
10. Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.
Kanters JK; Skibsbye L; Hedley PL; Dembic M; Liang B; Hagen CM; Eschen O; Grunnet M; Christiansen M; Jespersen T
Scand J Clin Lab Invest; 2015; 75(8):699-709. PubMed ID: 26403377
[TBL] [Abstract][Full Text] [Related]
11. LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation.
Stump MR; Gong Q; Zhou Z
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1397-404. PubMed ID: 23997099
[TBL] [Abstract][Full Text] [Related]
12. Partially dominant mutant channel defect corresponding with intermediate LQT2 phenotype.
Krishnan Y; Zheng R; Walsh C; Tang Y; McDonald TV
Pacing Clin Electrophysiol; 2012 Jan; 35(1):3-16. PubMed ID: 21951015
[TBL] [Abstract][Full Text] [Related]
13. Functional studies on three novel HCNH2 mutations in Taiwan: identification of distinct mechanisms of channel defect and dissociation between glycosylation defect and assembly defect.
Hsueh CH; Chen WP; Lin JL; Liu YB; Su MJ; Lai LP
Biochem Biophys Res Commun; 2008 Sep; 373(4):572-8. PubMed ID: 18593567
[TBL] [Abstract][Full Text] [Related]
14. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome.
Rossenbacker T; Mubagwa K; Jongbloed RJ; Vereecke J; Devriendt K; Gewillig M; Carmeliet E; Collen D; Heidbüchel H; Carmeliet P
Circulation; 2005 Mar; 111(8):961-8. PubMed ID: 15699249
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2.
Gu K; Qian D; Qin H; Cui C; Fernando WCHA; Wang D; Wang J; Cao K; Chen M
Pflugers Arch; 2021 Feb; 473(2):219-229. PubMed ID: 33449212
[TBL] [Abstract][Full Text] [Related]
16. The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
Hedley PL; Kanters JK; Dembic M; Jespersen T; Skibsbye L; Aidt FH; Eschen O; Graff C; Behr ER; Schlamowitz S; Corfield V; McKenna WJ; Christiansen M
Circ Cardiovasc Genet; 2013 Oct; 6(5):452-61. PubMed ID: 24021552
[TBL] [Abstract][Full Text] [Related]
17. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
[TBL] [Abstract][Full Text] [Related]
18. Identification of Kv11.1 isoform switch as a novel pathogenic mechanism of long-QT syndrome.
Gong Q; Stump MR; Deng V; Zhang L; Zhou Z
Circ Cardiovasc Genet; 2014 Aug; 7(4):482-90. PubMed ID: 25028483
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.
Liu L; Hayashi K; Kaneda T; Ino H; Fujino N; Uchiyama K; Konno T; Tsuda T; Kawashiri MA; Ueda K; Higashikata T; Shuai W; Kupershmidt S; Higashida H; Yamagishi M
Heart Rhythm; 2013 Jan; 10(1):61-7. PubMed ID: 23010577
[TBL] [Abstract][Full Text] [Related]
20. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
